CompanyDrug

Vcanbio’s Stem Cell Therapy VUM02 Gets NMPA Approval for Systemic Sclerosis Clinical Trial

CompanyDeals

Insilico Medicine Partners with Inimmune Corporation to Utilize AI for Immunotherapy Innovation

Policy / Regulatory

NHC Releases Updated List of Pediatric Drugs for Research and Development Incentives

CompanyDrug

Innovent Biologics’ Dupert Demonstrates Positive Results in Phase II NSCLC Trial

DrugPolicy / Regulatory

China’s CDE Issues Draft Guidelines for Biosimilar Pharmaceutical Similarity Research

CompanyDeals

Tigermed Partners with Purpose Africa to Boost Clinical Research and Healthcare Cooperation

Policy / Regulatory

China’s 2024 Negative List Eases Restrictions on Foreign Investment in TCM and Biotechnology

Policy / Regulatory

China’s NMPA Proposes Inclusion of Cochlear Implants in Volume-Based Procurement Plans

CompanyDeals

Edwards Lifesciences Sells ICU Business to BD in $4.2 Billion Deal, Announces Layoffs

CompanyDrug

Zelgen Biopharma’s ZG006 Shows Promising Anti-Tumor Efficacy in Phase I/II SCLC Study

Policy / Regulatory

China’s NHSA Proposes New Guidelines to Enhance Oversight of Medical Insurance Funds

CompanyDeals

Caprico Biotechnologies and Mindray Medical Form Comprehensive Flow Testing Partnership